/

Batteries & E-Mobility

/

Agios Pharmaceuticals

Agios Pharmaceuticals

Agios Pharmaceuticals

Verified Nov 2026

Batteries & E-Mobility

·

United States flag

Cambridge, Massachusetts

·

Since 2008

Agios Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts, founded in 2007 and employing 500 to 1,000 people. The company develops small-molecule drugs targeting rare diseases and cancer metabolism, with two approved oncology medicines: PYRUKYND for pyruvate kinase deficiency and AQVESME for thalassemia. Agios serves the medical and industrial equipment sectors through precision therapies.

Agios Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

2008

Headquarters

United States flag

Cambridge, Massachusetts

Employees

500-1,000

Ownership

Agios Pharmaceuticals at a glance

Revenue

$50-100M

Est. band

Employees

500-1,000

Founded

2008

Headquarters

Cambridge, Massachusetts

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Agios Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts, founded in 2007 and employing 500 to 1,000 people. The company develops small-molecule drugs targeting rare diseases and cancer metabolism, with two approved oncology medicines: PYRUKYND for pyruvate kinase deficiency and AQVESME for thalassemia. Agios serves the medical and industrial equipment sectors through precision therapies.

At a glance

Attribute

Detail

Founded

2008

Headquarters

Cambridge, Massachusetts

Employees

500-1,000

Revenue

$50-100M (estimated)

Primary capability

Batteries & E-Mobility

What Agios Pharmaceuticals makes

The company maintains a pipeline of investigational therapies targeting sickle cell disease and phenylketonuria alongside its two approved precision medicines.

Latest developments

Company details

Agios is publicly traded on NASDAQ under ticker AGIO with a market capitalization of approximately $2.2 billion. Agios Pharmaceuticals was founded in 2008, has an estimated 500-1,000 employees, and is headquartered in Cambridge, Massachusetts.

Frequently asked questions

What does Agios Pharmaceuticals make?

Agios Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts, founded in 2007 and employing 500 to 1,000 people. The company develops small-molecule drugs targeting rare diseases and cancer metabolism, with two approved oncology medicines: PYRUKYND for pyruvate kinase deficiency and AQVESME for thalassemia. Agios serves the medical and industrial equipment sectors through precision therapies.

Where is Agios Pharmaceuticals headquartered?

Agios Pharmaceuticals is headquartered in Cambridge, Massachusetts (88 Sidney Street, Cambridge, Massachusetts, 02139).

When was Agios Pharmaceuticals founded?

Agios Pharmaceuticals was founded in 2008.

How big is Agios Pharmaceuticals?

Agios Pharmaceuticals has an estimated 500-1,000 employees, with revenue in the $50-100M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Cambridge, Massachusetts (HQ)Headquarters · United States
Cambridge, Massachusetts (HQ)88 Sidney Street, Cambridge, Massachusetts, 02139, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.